Related Experiment Video
Updated: Aug 15, 2026

09:23
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Immune suppressor substance in experimental chagas disease
1Eddy Liew is Head o f Experimental Immuno-biology at the Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, UK.
Parasitology Today (Personal Ed.)
|December 1, 1988
Summary
Parasitic infections like Chagas disease can cause immune suppression. This review questions the biological significance of suppressor substances in Trypanosoma cruzi infections due to their restricted production in mice.
Area of Science:
- Immunology
- Parasitology
- Molecular Biology
Background:
- Parasitic infections are known to induce immune suppression, impacting host defense mechanisms.
- In Chagas disease, soluble suppressor substances have been observed in experimental models, but their identity and source are unclear.
- Understanding immune modulation in parasitic diseases is crucial for developing effective treatments.
Purpose of the Study:
- To review recent findings on immune suppression in mouse models of Chagas disease.
- To explore the nature, origin, and biological significance of suppressor substances in Trypanosoma cruzi infections.
- To discuss the potential role of immune suppression in balancing host immunity and autoimmunity.
Main Methods:
- Review of existing literature on immune suppression in murine models of Chagas disease.
- Analysis of findings related to soluble suppressor substances produced during Trypanosoma cruzi infection.
- Examination of genetic factors influencing suppressor substance production in inbred mouse strains.
Main Results:
- Evidence suggests the production of suppressor substances during Trypanosoma cruzi infection in mice.
- The production of these suppressor substances appears to be genetically restricted.
- The exact nature and origin of these substances remain to be fully elucidated.
Conclusions:
- Suppressor substances may represent a mechanism to balance protective immunity against autoimmune risks.
- The genetic restriction of suppressor substance production raises questions about its broader biological relevance.
- Further research is needed to clarify the role and significance of immune suppression in Chagas disease.
Related Concept Videos
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

